The effects of cannabis and cannabinoids on the endocrine system
- PMID: 34460075
- DOI: 10.1007/s11154-021-09682-w
The effects of cannabis and cannabinoids on the endocrine system
Abstract
With the increase in cannabis use due to policy changes and areas of decriminalization, it is important to recognize the potential impact of these substances on endocrine processes. Cannabinoids have many effects by activating the endocannabinoid system. This system plays a role in the normal functioning of nearly every organ and consists of the body's natural endocannabinoids, the cannabinoid receptors, and the enzymes and processes that regulate endocannabinoids. Exogenous cannabinoids such as Δ9-tetrahydrocannabinol (THC) are known to act through cannabinoid type 1 and 2 receptors, and have been shown to mimic endocannabinoid signaling and affect receptor expression. This review summarizes the known impacts of cannabis on thyroid, adrenal, and gonadal function in addition to glucose control, lipids, and bone metabolism, including: reduced female fertility, increased risk of adverse pregnancy outcomes, reduced sperm counts and function, lower thyroid hormone levels with acute use, blunting of stress response with chronic use, increased risk of prediabetes but lower risk of diabetes, suggested improvement of high density lipoproteins and triglycerides, and modest increase in fracture risk. The known properties of endocannabinoids, animal data, population data, and the possible benefits and concerns of cannabinoid use on hormonal function are discussed. The interconnectivity of the endocrine and endocannabinoid systems suggests opportunities for future therapeutic modalities which are an area of active investigation.
Keywords: Bone; Cannabis; Diabetes; Endocannabinoids; Fertility; Thyroid.
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Similar articles
-
The Endocannabinoid System Modulating Levels of Consciousness, Emotions and Likely Dream Contents.CNS Neurol Disord Drug _targets. 2017;16(4):370-379. doi: 10.2174/1871527316666170223161908. CNS Neurol Disord Drug _targets. 2017. PMID: 28240187 Review.
-
Endocannabinoid System: A Multi-Facet Therapeutic _target.Curr Clin Pharmacol. 2016;11(2):110-7. doi: 10.2174/1574884711666160418105339. Curr Clin Pharmacol. 2016. PMID: 27086601 Review.
-
The evolution of cannabinoid receptors in cancer.WIREs Mech Dis. 2023 Jul-Aug;15(4):e1602. doi: 10.1002/wsbm.1602. Epub 2023 Feb 7. WIREs Mech Dis. 2023. PMID: 36750231 Free PMC article. Review.
-
Role of lipids and lipid signaling in the development of cannabinoid tolerance.Life Sci. 2005 Aug 19;77(14):1543-58. doi: 10.1016/j.lfs.2005.05.005. Life Sci. 2005. PMID: 15949820 Review.
-
Cannabis, cannabinoids and reproduction.Prostaglandins Leukot Essent Fatty Acids. 2004 Feb;70(2):189-97. doi: 10.1016/j.plefa.2003.04.007. Prostaglandins Leukot Essent Fatty Acids. 2004. PMID: 14683692 Review.
Cited by
-
Clearing up the smoke: Physical and mental health considerations regarding cannabis use in adolescents with cystic fibrosis.Pediatr Pulmonol. 2023 Feb;58(2):398-407. doi: 10.1002/ppul.26241. Epub 2022 Nov 18. Pediatr Pulmonol. 2023. PMID: 36349504 Free PMC article. Review.
-
Cannabis- and Substance-Related Epidemiological Patterns of Chromosomal Congenital Anomalies in Europe: Geospatiotemporal and Causal Inferential Study.Int J Environ Res Public Health. 2022 Sep 6;19(18):11208. doi: 10.3390/ijerph191811208. Int J Environ Res Public Health. 2022. PMID: 36141481 Free PMC article.
-
Cannabis and cannabinoids in dermatology: protocol for a systematic review and meta-analysis of quantitative outcomes.BMJ Open. 2023 Sep 12;13(9):e075007. doi: 10.1136/bmjopen-2023-075007. BMJ Open. 2023. PMID: 37699631 Free PMC article.
-
Assessing the effectiveness of cannabidiol additive supplementation on canine behavior and cortisol levels.Heliyon. 2024 May 15;10(10):e31345. doi: 10.1016/j.heliyon.2024.e31345. eCollection 2024 May 30. Heliyon. 2024. PMID: 38803908 Free PMC article.
-
G Protein-Coupled Receptors in Osteoarthritis.Front Endocrinol (Lausanne). 2022 Jan 28;12:808835. doi: 10.3389/fendo.2021.808835. eCollection 2021. Front Endocrinol (Lausanne). 2022. PMID: 35154008 Free PMC article. Review.
References
-
- Substance Abuse Center for Behavior Health Statistics and Quality. Results from the 2018 National Survey on drug use and Health: Detailed Tables. SAMHSA. 2018. https://www.samhsa.gov/data/report/2018-nsduh-detailed-tables . Accessed 18 Jul 2021.
-
- WHO. The health and social effects of nonmedical cannabis use. 2016. https://www.who.int/substance_abuse/publications/cannabis_report/en/inde... . Accessed 20 Jul 2021.
-
- Pertwee R, Howlett A, Abood M, Alexander S, Di Marzo V, Elphick M, et al. International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid receptors and their ligands: beyond CB1 and CB2. Pharmacol Rev. 2010;62:588–631. https://doi.org/10.1124/PR.110.003004 .
-
- Rock E, Parker L. Constituents of Cannabis Sativa. Adv Exp Med Biol. 2021;1264:1–13. https://doi.org/10.1007/978-3-030-57369-0_1 . - DOI - PubMed
-
- Lewis M, Russo E, Smith K. Pharmacological Foundations of Cannabis Chemovars. Planta Med. 2018;84:225–33. https://doi.org/10.1055/S-0043-122240 . - DOI - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources